Delivery Order SPE2DB22D9367-SPE2DB24FSY72

Award Date 7/11/24
Potential Completion Date 8/1/24
Potential Value $20K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,143.86 contract is for the delivery of 1,000 unit vials of the coagulation factor Kcentra. This delivery order is issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the agency to order a comprehensive range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,648.80 contract is for the delivery of 4,565,936 units of the blood coagulation factor KCENTRA 500 unit vials. This order is placed under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which allows the agency to issue delivery orders for a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $20,483.52 firm fixed-price contract is for the delivery of 1,000 units of the blood coagulation factor Kcentra. The contract has an ultimate completion date of July 12, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,152.48 contract is for the delivery of 1,000 unit vials of the blood coagulation factor KCENTRA. The delivery order was issued under a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA's Medical Supply Chain division. This IDC...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $17,284.80, is for the delivery of 1,000 unit vials of the drug Kcentra. This delivery order is issued under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the DLA to issue firm...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,124.80 contract is for the delivery of 1,000 unit vials of the specialized medication Kcentra by August 27, 2024. This delivery order is part of a larger single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $78,466.75 contract is for the delivery of 1,000 unit vials of the pharmaceutical product Kcentra. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which enables the DLA to issue...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $6,602.88 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 1,000 unit vials of the blood coagulant Kcentra, with a completion date of October 9, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $18,714.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 1,000 unit vials of the specialty pharmaceutical product Kcentra. This delivery order is issued under DMS Pharmaceutical Group's larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the agency to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,448.32 contract is for the delivery of 1,000 unit vials of the medication Kcentra by February 14, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a wide...
  • SPE2DB22D9367
    Indefinite Delivery Contract
  • SPE2DB22D9367-SPE2DB24FSY72
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $20,364.96 contract is for the delivery of 1,000 unit vials of the blood coagulation factor Kcentra. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a wide range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. There is no set-aside designation for this specific delivery order. Through this and other prime vendor contracts, DMS Pharmaceutical Group provides a comprehensive assortment of branded and generic prescription drugs, biologics, and medical supplies to the Department of Defense and Department of Veterans Affairs.

Generated 10/10/24, 9:15 AM